Literature DB >> 29176262

Elevated Plasma Levels of Gas6 Are Associated with Acute Lung Injury in Patients with Severe Sepsis.

Li-Chun Yeh1, Ping-Wun Huang1, Kuan-Hsian Hsieh2, Chung-Hsuan Wang3, Yi-Kai Kao1, Tzu-Hsiang Lin4, Xiao-Lun Lee1.   

Abstract

Acute lung injury (ALI) is one of the complications of severe sepsis, causing sudden deaths. However, information regarding predictive factors for the onset of ALI in severe sepsis is limited. Growth arrest-specific gene 6 (Gas6) is secreted by endothelial cells and is important for the activation of endothelium during inflammation. This study aimed to investigate the predictive effect of plasma Gas6 in patients with severe sepsis. Collection of plasma samples was carried out from 129 participants with severe sepsis following with or without ALI development. We found that the elevated levels of Gas6, interleukin-6 and -8 (IL-6 and IL-8) in plasma were associated with the ALI development (P = 0.003, 0.002, and 0.004, respectively). We also observed the robust correlation between the plasma level of Gas6 and the following ALI development to adjustment for sepsis and administration of vasopressor. Between patients with ALI (n = 18) and those without ALI (n = 111), Gas6 and the Lung Injury Prediction Score (LIPS) showed promising discrimination (AUROC, 0.74 and 0.68, respectively), and in combination with these two indexes, the AUROC was increased to 0.86 (vs. 0.74, P = 0.05), while soluble receptor for advanced glycation end products (sRAGE) and Willebrand factor (vWF) in plasma showed no predictive value for of ALI. Collectively, our findings indicate that higher levels of Gas6 in plasma are obviously correlated with ALI development. An early increase in the plasma Gas6 level suggests that endothelial injury is a key link in the pathogenesis of ALI.

Entities:  

Keywords:  Growth arrest-specific gene 6 (Gas6); acute lung injury; interleukin-6; interleukin-8; sepsis

Mesh:

Substances:

Year:  2017        PMID: 29176262     DOI: 10.1620/tjem.243.187

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  9 in total

1.  Utility of Serum Growth Arrest-Specific Protein 6 as a Biomarker of Severity and Prognosis After Severe Traumatic Brain Injury: A Prospective Observational Study.

Authors:  Bu-Kao Ni; Jian-Yong Cai; Xiao-Bo Wang; Qun Lin; Xue-Na Zhang; Jian-Hua Wu
Journal:  Neuropsychiatr Dis Treat       Date:  2022-07-14       Impact factor: 2.989

2.  Exosomes from Endothelial Progenitor Cells Improve the Outcome of a Murine Model of Sepsis.

Authors:  Yue Zhou; Pengfei Li; Andrew J Goodwin; James A Cook; Perry V Halushka; Eugene Chang; Hongkuan Fan
Journal:  Mol Ther       Date:  2018-02-27       Impact factor: 11.454

Review 3.  Gas6/TAM Axis in Sepsis: Time to Consider Its Potential Role as a Therapeutic Target.

Authors:  Livia Salmi; Francesco Gavelli; Filippo Patrucco; Marina Caputo; Gian Carlo Avanzi; Luigi Mario Castello
Journal:  Dis Markers       Date:  2019-08-14       Impact factor: 3.434

4.  A systematic review of biomarkers multivariately associated with acute respiratory distress syndrome development and mortality.

Authors:  Philip van der Zee; Wim Rietdijk; Peter Somhorst; Henrik Endeman; Diederik Gommers
Journal:  Crit Care       Date:  2020-05-24       Impact factor: 9.097

Review 5.  Systematic review of diagnostic methods for acute respiratory distress syndrome.

Authors:  Laura A Hagens; Nanon F L Heijnen; Marry R Smit; Marcus J Schultz; Dennis C J J Bergmans; Ronny M Schnabel; Lieuwe D J Bos
Journal:  ERJ Open Res       Date:  2021-01-18

6.  Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome.

Authors:  Albert Morales; Silvia Rojo Rello; Helena Cristóbal; Aida Fiz-López; Elisa Arribas; Montserrat Marí; Anna Tutusaus; Paloma de la Cal-Sabater; Gerry A F Nicolaes; José T Ortiz-Pérez; David Bernardo; Pablo García de Frutos
Journal:  Biomedicines       Date:  2021-03-26

7.  Are Baseline Levels of Gas6 and Soluble Mer Predictors of Mortality and Organ Damage in Patients with Sepsis? The Need-Speed Trial Database.

Authors:  Francesco Gavelli; Luca Molinari; Marco Baldrighi; Livia Salmi; Filippo Mearelli; Nicola Fiotti; Filippo Patrucco; Chiara Airoldi; Mattia Bellan; Pier Paolo Sainaghi; Salvatore Di Somma; Enrico Lupia; Efrem Colonetti; Maria Lorenza Muiesan; Gianni Biolo; Gian Carlo Avanzi; Luigi Mario Castello
Journal:  Biomedicines       Date:  2022-01-18

8.  Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients.

Authors:  Robert Frithiof; Gerry A F Nicolaes; Joram Huckriede; Sara Bülow Anderberg; Albert Morales; Femke de Vries; Michael Hultström; Anders Bergqvist; José T Ortiz-Pérez; Jan Willem Sels; Kanin Wichapong; Miklos Lipcsey; Marcel van de Poll; Anders Larsson; Tomas Luther; Chris Reutelingsperger; Pablo Garcia de Frutos
Journal:  Sci Rep       Date:  2021-08-03       Impact factor: 4.379

Review 9.  Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation.

Authors:  Barbara Bonnesen; Jens-Ulrik Stæhr Jensen; Klaus Nielsen Jeschke; Alexander G Mathioudakis; Alexandru Corlateanu; Ejvind Frausing Hansen; Ulla Møller Weinreich; Ole Hilberg; Pradeesh Sivapalan
Journal:  Diagnostics (Basel)       Date:  2021-12-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.